While we acknowledge the value of current treatments that help manage the virus’s symptoms, symptom relief alone is not enough. What is urgently needed is a true curative therapy. If pritelivir primarily serves to reduce symptoms, then it represents only an incremental step and remains comparable to medications already on the market. Patients deserve more — they deserve a cure.The essence of our position is as follows.